China RapiMed
Post# of 7769
Scrips chose the perfect product for China. With the loosening of the one-child restriction there, experts predict the annual birth rate in China to increase by 1M to 2M over the current annual birth rate their of about 16M newborns. (China ends reeducation through labour and loosens one child policy http://flip.it/fK46O)
This is an increase of about 6.25% to 12.5%, which will result in an OTC pediatric market in China between $11.7M and $12.4B by 2015 (each quarter percent of that market range is $29.25M and $31M). Considering nothing like Children's RapiMed exists in China, I believe it is reasonable to expect a quarter percent of that market by 2015.
Only 1.5 more trading days until 2014...
GLTA the loyal and faithful longs here!